Resources
About Us
Home Report
Store
Biopharmaceutical Processing Equipment and Consumables Market
Biopharmaceutical Processing Equipment and Consumables Market Size, Share, Forecast, & Trends Analysis by Product Type (Filtration, Chromatography, Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D) - Global Forecast to 2031
Report ID:MRHC - 10458 Pages: 294 Aug-2024 Formats*: PDF Category: Healthcare Delivery: 2 to 4 HoursThe Biopharmaceutical Processing Equipment and Consumables Market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.
Biopharmaceutical Processing Equipment and Consumables Market Size & Forecast
The growth of this market is driven by the growing biopharmaceuticals market, biopharmaceutical plant capacity expansions, and the rising adoption of single-use bioprocessing equipment. Furthermore, emerging economies, the shift toward bioprocessing 4.0, and the rising adoption of personalized medicines are expected to generate growth opportunities for the stakeholders in this market.
Biopharmaceutical Processing Equipment and Consumables Market Growth Drivers
Growing Adoption of Single-use Bioprocessing Equipment for Commercial Production
For many years, the biopharmaceutical processing industry has been dominated by stainless-steel/reusable equipment. The majority of biopharmaceutical manufacturing facilities contain fixed mixers, bioprocessing vessels, and bioreactors made of stainless steel. However, in recent years, the tendency has shifted in favor of single-use/disposable equipment adoption. This is explained by the equipment's many benefits over traditional stainless-steel equipment, including lower manufacturing costs (due to the elimination of cleaning and validation stages).
Besides reducing the time and labor required, single-use technologies also help reduce capital costs and energy consumption, improving efficiency. Single-use systems have a lower carbon footprint than permanent steel systems, despite producing waste from the burning and disposal of plastic materials. There is significantly more carbon dioxide released during the steam-in-place sterilization of stainless-steel vessels, pipes, and other hardware, and during the steam-generation process for water for injection (WFI) cleaning than there is during the production and disposal of single-use plastic systems.
Thus, incorporating single-use platforms significantly reduces the usage of WFI, steam, and cleaning agents.
Click here to: Get Free Sample Pages of this Report
Capacity Expansions of Biopharmaceutical Plants
Biosimilars and biologics are gaining significant importance in oncology, autoimmune diseases, and rare diseases. To meet the growing demand for biopharmaceuticals, several manufacturers are expanding their manufacturing facilities. These capacity expansions from biopharmaceutical manufacturers and CDMOs will generate additional demand for biopharmaceutical manufacturing equipment and consumables and thereby propel market growth. Some of the instances for biopharmaceutical plants capacity include:
- In January 2024, AbbVie Inc. (U.S.) expanded its biologics manufacturing facility in Singapore with an investment of USD 223 million.
- In November 2023, Eli Lilly and Company (U.S.) opened a new facility, with an investment of USD 2.5 billion for the capacity of the company’s parenteral (injectable) product.
Biopharmaceutical Processing Equipment and Consumables Market Trends
Growing Focus on Continuous Bioprocessing
The batch/fed-batch method has long dominated the production of biopharmaceuticals. It is not without limits, but as compared to continuous bioprocessing, it has higher operating costs and necessitates additional instruments for feedback control. Unlike batch culture, which produces a specific quantity of product in a discrete volume during the same cycle of manufacture, continuous bioprocessing involves processing the intermediate or final product at a specific location without interruption due to a continuous flow of raw materials into and out of the bioreactor. The procedure is usually broken down into numerous discrete parts, many of which are carried out at various locations. Additionally, continuous processing produces a high-quality final product that is uniform in providing lower capital costs, improving process flow, smaller equipment size, and steady-state operation.
Due to the growing demand for innovative and complex therapies and the increasing competition in the biopharmaceuticals market, biopharmaceutical manufacturers are reconsidering manufacturing methods (shifting from batch to continuous manufacturing). Although batch manufacturing is the most preferred method, continuous manufacturing is increasingly accepted in the pharmaceutical industry due to its commercial advantages.
Strong R&D Pipeline of Biopharmaceuticals
At present, antibody-based biopharmaceuticals are dominating the market. There is a large number of antibody-based biopharmaceuticals present in the clinical pipeline of various biopharmaceutical companies. Twenty-one experimental antibody treatments are undergoing regulatory review in the United States and the European Union as of January 10, 2021, according to statistics given by The Antibody Society, an international non-profit research and development organization focused on antibodies. In the United States or the European Union, thirteen antibody medicines received initial approvals between January 1, 2021, and December 31, 2021. Moreover, fifty-five innovative medications and biological products were approved by the Center for Drug Evaluation and Research (CDER) in 2023.
Thus, with more biopharmaceuticals entering a commercial stage, the demand for bioprocessing equipment and consumables used in their production is expected to grow.
Biopharmaceutical Processing Equipment and Consumables Market Opportunities
Shift Towards Bioprocessing 4.0
The rapid development in emerging economies, progressing research in biologics, and the growing penetration of biopharmaceuticals have created tremendous opportunities for biopharmaceutical manufacturers, boosting the demand for biopharmaceutical processing equipment and consumables. The manufacturing of biologics has grown over the last few years. The industry is shifting towards Bioprocessing 4.0, a term derived from Industry 4.0, which is a national strategic initiative launched by the German government in 2010. The era of biomanufacturing 4.0 is still young. An end-to-end connected bioprocess, or bioprocessing 4.0, is characterized by all systems and equipment being digitally connected to form the Industrial Internet of Things (IoT), which allows the process to be run, controlled, and improved through artificial intelligence (AI) and machine learning.
Biopharmaceutical Processing Equipment and Consumables Market Analysis: Key Findings
By Product Type: In 2024, the Filtration Segment is Expected to Dominate the Biopharmaceutical Processing Equipment and Consumables Market
Based on product type, the global biopharmaceutical processing equipment and consumables market is segmented into filtration systems, chromatography equipment and consumables, bioreactors, cell culture products, mixers/mixing systems, bioprocessing containers, sterilizers, centrifuges, incubators, shakers, biosafety cabinets, and other consumables and accessories. In 2024, the filtration systems segment is estimated to account for the largest share of 22.3% of the global biopharmaceutical processing equipment and consumables market. The large share of this segment is attributed to the recurring use of filtration at every step in bioprocessing and technological advancements in filtration technologies.
Filtration is a basic requisite across all stages of bioproduction. It is commonly used in biopharmaceutical processing to separate components. It is also used in various downstream operations, such as clarification, filtration of intermediates, critical final filling applications, or upstream processing for sterilizing-grade filtration of cell culture media.
However, the bioreactors segment is expected to grow at the highest CAGR of 17.1% during the forecast period of 2024 to 2031. The accelerated development of biopharmaceuticals for therapeutic indications like cancer, rare diseases, and infectious diseases; new product developments; and the growing deployment of single-use bioprocessing technologies are the factors driving the growth of the bioreactors segment.
Bioreactors, also called fermenters, are containers that provide an ideal environment for enzymes or whole cells to transform biochemicals into products. Bioreactors are used for many applications, including cell growth, enzyme production, biocatalysis, tissue engineering, algae production, protein synthesis, and anaerobic digestion. According to the Pharmaceutical Research and Manufacturers of America (PhRMA) (U.S.), currently, there are over 8,000 medicines in development, out of which 74% are potential first-in-class indicators for cancer, cardiovascular disorders, diabetes, Alzheimer’s disease, and rare diseases. As bioreactors are essential for the manufacturing of biopharmaceuticals, the growing development of biologics and biosimilars drives the segment growth during the forecast period.
By Application: In 2024, the Commercial Bioproduction Segment is Expected to Dominate the Biopharmaceutical Processing Equipment and Consumables Market
Based on application, the global biopharmaceutical processing equipment and consumables market is segmented into commercial bioproduction and research bioproduction. In 2024, The commercial bioproduction segment is estimated to account for the larger share of 77.5% of the global biopharmaceutical processing equipment and consumables market.
Growing initiatives supporting the adoption of biopharmaceuticals, rising biopharmaceutical manufacturing outsourcing, and accelerated developments in personalized therapies are likely to enhance the demand for bioprocessing equipment and consumables for the commercial bioproduction of monoclonal antibodies (mAbs), vaccines, gene therapies, and recombinant protein-based therapies.
A large number of pharmaceutical companies and contract manufacturing organizations (CMOs) involved in the manufacturing of biopharmaceuticals are witnessing high demand to produce biopharmaceuticals. In order to cater to the increasing demand, they are expanding their present manufacturing capacities, which would further increase the demand for biopharmaceutical equipment and consumables for commercial bioproduction during the forecast period. Besides this, the growing prevalence of various chronic & infectious diseases and regulatory reforms favoring the adoption of biosimilars are expected to drive the growth of the commercial bioproduction segment at the highest CAGR of 10.1% during the forecast period of 2024 to 2031.
By End User: In 2024, the Pharmaceutical and Biopharmaceutical Companies Segment is Expected to Account for the Largest Share of the Biopharmaceutical Processing Equipment and Consumables Market
Based on end-user, the global biopharmaceutical processing equipment and consumables market is categorized into pharmaceutical & biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic & research institutes. In 2024, the pharmaceutical and biopharmaceutical companies segment is estimated to account for the largest share of the market.
The largest market share is attributable to the capacity expansion of biopharmaceutical manufacturers and the growing adoption of biopharmaceutical processing equipment for bioproduction. Biopharmaceuticals account for nearly 25% of the pharmaceutical market, and the development and manufacturing of biopharmaceuticals are gaining pace. Thus, the growing manufacturing of biopharmaceuticals by biopharmaceutical companies contributes to the large segment share.
However, the contract development and manufacturing organizations (CDMO) segment is expected to grow with the highest CAGR during the forecast period of 2024 to 2031. The growth of the segment is attributed to the growing preference of pharmaceutical and biopharmaceutical companies to outsource development and manufacturing to CDMOs due to the cost, operational, and regulatory advantages offered by CDMOs.
Biopharmaceutical Processing Equipment and Consumables Market Geographical Analysis
In 2024, Europe is estimated to account for the largest share of 33.5% of the global biopharmaceutical processing equipment and consumables market. The large share of Europe in the biopharmaceutical processing equipment and consumables market is primarily attributed to the presence of leading biopharmaceutical manufacturers in the region, growing exports from Switzerland and Denmark, and the expansion of biopharmaceutical companies. Additionally, rising production capacities of the vaccine manufacturing plants, to meet the growing demand for COVID-19 vaccines has also contributed to the largest market.
However, Asia-Pacific is expected to grow at the highest CAGR of 12.6% during the forecast period. This market's growth is attributed to factors like the increasing outsourcing of biopharmaceutical manufacturing in countries like China, India, Singapore, and South Korea; rising public & private initiatives to boost biotechnology research for the development of novel treatments for chronic diseases; and growing initiatives supporting the adoption of biopharmaceuticals. Furthermore, growing awareness of personalized medicines and the development of biotechnology incubators are also accelerating the market growth.
Key Companies
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years. The key players profiled in the global biopharmaceutical processing equipment and consumables market report are 3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Biopharmaceutical Processing Equipment and Consumables Industry Overview: Latest Developments from Key Industry Players
- In April 2023, Cytiva (U.S.) launched X-platform bioreactors to streamline the single-use upstream bioprocessing operations.
- In May 2024, Waters Corporation (U.S.) introduced the next-generation Alliance iS Bio HPLC System to increase the efficiency of quality control biopharmaceutical labs and reduce errors.
- In September 2023, Getinge AB (Sweden) launched AppliFlex ST GMP, a single-use bioreactor, to increase the efficiency of research and clinical production in cell and gene therapy and mRNA production.
Biopharmaceutical Processing Equipment and Consumables Market Research Summary
|
Particulars |
Details |
|
Number of Pages |
294 |
|
Format |
|
|
Forecast Period |
2024–2031 |
|
Base Year |
2023 |
|
CAGR (Value) |
9.5% |
|
Market Size (Value) |
USD 75.72 Billion by 2031 |
|
Segments Covered |
By Product Type
By Application
By End User
|
|
Countries Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Belgium, Ireland, Denmark, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), Latin America, and Middle East & Africa |
|
Key Companies |
3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).). |
Key questions answered in the biopharmaceutical processing equipment and consumables market report:
This study offers a detailed assessment of the biopharmaceutical processing equipment and consumables market, including the market size & forecast for various segmentations like product type, application, and end user. The biopharmaceutical processing equipment and consumables market studied in this report also involves the value analysis of various segments and subsegments of biopharmaceutical processing equipment and consumables at regional and country levels.
The global biopharmaceutical processing equipment and consumables market was valued at $36.38 billion in 2023. This market is expected to reach $75.72 billion by 2031 from an estimated $40.22 billion in 2024, at a CAGR of 9.5% during the forecast period of 2024-2031.
In 2024, the filtration systems segment is estimated to account for the largest share, 22.3%, of the global biopharmaceutical processing equipment and consumables market. This segment's large share is attributed to the recurring use of filtration at every step in bioprocessing and technological advancements in filtration technologies.
Based on application, the commercial bioproduction segment is expected to grow at the highest CAGR over the forecast period. A large number of biopharmaceuticals in clinical development and nearing patent expirations of biologics are the key factors supporting the market growth.
The growth of this market is mainly attributed to the global initiatives supporting the adoption of biopharmaceuticals, capacity expansions of biopharmaceutical plants, and the growing adoption of single-use bioprocessing equipment and consumables. Moreover, emerging economies, the shift towards bioprocessing 4.0, and the rising adoption of personalized medicines offer significant opportunities for market growth.
The key players profiled in the global biopharmaceutical processing equipment and consumables market are 3M Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Agilent Technologies, Inc (U.S.), Repligen Corporation (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Eppendorf AG (Germany), and Solaris Biotechnology Srl (Italy).
Emerging economies like China and India are projected to offer significant growth opportunities to the market players due to the growing outsourcing of biopharmaceutical development and manufacturing, favorable government initiatives to support biopharmaceutical manufacturing, and public and private initiatives to support pharmaceutical and biopharmaceutical growth.
Related Tag:
Biopharmaceutical Processing Equipment and Consumables Market
Biopharmaceuticals Manufacturing
Biopharmaceutical Processing
Biosimilars Processing
Commercial Bioproduction
Research Bioproduction
Processing Equipment and Consumables
Antibody Production
Biomanufacturing
Biologics Manufacturing
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Size and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Growing Biopharmaceuticals Market
4.2.1.1.1. Rising Adoption of Biopharmaceuticals
4.2.1.1.2. Strong R&D Pipeline for Biopharmaceuticals
4.2.1.1.3. Government Initiatives
4.2.1.2. Biopharmaceutical Plant Capacity Expansions
4.2.1.3. Rising Adoption of Single-use Bioprocessing Equipment
4.2.2. Restraints
4.2.2.1. Complexities in the Development & Manufacturing of Biopharmaceuticals
4.2.3. Opportunities
4.2.3.1. Emerging Economies
4.2.3.2. Shift Toward Bioprocessing 4.0
4.2.3.3. Rising Adoption of Personalized Medicines
4.2.4. Challenges
4.2.4.1. Intensive Capital Requirements for Biopharmaceutical Production
4.3. Market Trends
4.3.1. Use of Disposable Processing Equipment for Commercial Production
4.3.2. Rising Focus on Continuous Bioprocessing
4.4. Regulatory Analysis
4.4.1. North America
4.4.1.1. U.S.
4.4.1.2. Canada
4.4.2. Europe
4.4.3. Asia-Pacific
4.4.3.1. Japan
4.4.3.2. China
4.4.3.3. India
4.4.4. Latin America
4.4.5. Middle East & Africa
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Suppliers
4.6.2. Bargaining Power of Buyers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Global Biopharmaceutical Processing Equipment and Consumables Market—by Product Type
5.1. Overview
5.2. Filtration Systems
5.3. Chromatography Equipment and Consumables
5.3.1. Chromatography Consumables
5.3.2. Chromatography Equipment
5.4. Bioreactors
5.4.1. Single-use Bioreactors
5.4.2. Reusable Bioreactors
5.5. Cell Culture Products
5.5.1. Cell Culture Media
5.5.1.1. Cell Culture Media, by Physical Form
5.5.1.1.1. Dry Powder Media
5.5.1.1.2. Liquid Media
5.5.1.2. Cell Culture Media, by Type
5.5.1.2.1. Off-the-Shelf Media
5.5.1.2.2. Custom Media
5.5.1.3. Cell Culture Media, by Source
5.5.1.3.1. Chemically Defined Media
5.5.1.3.2. Natural Media
5.5.2. Reagents and Supplements
5.5.3. Cells and Cell Lines
5.5.4. Cell Culture Serum
5.6. Bioprocessing Containers (BPC)
5.7. Sterilizers
5.8. Mixers/Mixing Systems
5.9. Incubators
5.10. Centrifuges
5.11. Shakers
5.12. Biosafety Cabinets
5.13. Other Consumables and Accessories
5.14. Support Services
6. Biopharmaceutical Processing Equipment and Consumables Market—by Application
6.1. Overview
6.2. Commercial Bioproduction
6.2.1. Monoclonal Antibody Production
6.2.2. Therapeutic Protein Production
6.2.3. Vaccine Production
6.2.4. Cell and Gene Therapy
6.3. Research Bioproduction
7. Biopharmaceutical Processing Equipment & Consumables Market—by End User
7.1. Overview
7.2. Pharmaceutical & Biopharmaceutical Companies
7.3. Contract Development and Manufacturing Organizations (CDMO)
7.4. Academic & Research Institutes
8. Biopharmaceutical Processing Equipment and Consumables Market—by Geography
8.1. Overview
8.2. Europe
8.2.1. Germany
8.2.2. France
8.2.3. U.K.
8.2.4. Italy
8.2.5. Spain
8.2.6. Ireland
8.2.7. Denmark
8.2.8. Belgium
8.2.9. Switzerland
8.2.10. Rest of Europe
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. South Korea
8.4.5. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa
9. Competitive Landscape
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis
9.5.1. Danaher Corporation (U.S.)
9.5.2. Thermo Fisher Scientific Inc. (U.S.)
9.5.3. Sartorius AG (Germany)
9.5.4. Agilent Technologies, Inc (U.S.)
10. Company Profiles
10.1. Thermo Fisher Scientific Inc.
10.2. Agilent Technologies, Inc.
10.3. Sartorius AG
10.4. Danaher Corporation
10.5. Merck KGaA
10.6. 3M Company
10.7. Bio-Rad Laboratories, Inc.
10.8. Eppendorf SE
10.9. Solaris Biotechnology Srl
10.10. Repligen Corporation
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Recent Biopharmaceutical Plant Capacity Expansions
Table 2 U.S.: Key FDA Regulations for the Biopharmaceutical Industry
Table 3 India: Laws Regulating the Biopharmaceutical Processing Industry
Table 4 Pricing Analysis: Biopharmaceutical Processing Equipment
Table 5 Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 6 Global Filtration Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 8 Global Chromatography Equipment and Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Types of Chromatography Resins
Table 10 Global Chromatography Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Chromatography Equipment Market, by Country/Region, 2022–2031(USD Million)
Table 12 Global Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 13 Global Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Single-Use Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Reusable Bioreactors Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 17 Global Cell Culture Products Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 19 Global Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 20 Global Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 21 Global Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Dry Powder Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Liquid Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Off-The-Shelf Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Custom Cell Culture Media Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Chemically Defined Cell Culture Media Market, by Country/Region,2022–2031 (USD Million)
Table 27 Global Natural Media Market, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Cell Culture Reagents and Supplements Market, by Country/ Region, 2022–2031 (USD Million)
Table 29 Global Cells and Cell Lines Market, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Cell Culture Serum Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Bioprocessing Containers Market, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Sterilizers Market, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Mixers/Mixing Systems Market, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Incubators Market, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Centrifuges Market, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Shakers Market, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Biosafety Cabinets Market, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Other Consumables and Accessories Market, by Country/ Region, 2022–2031 (USD Million)
Table 39 Global Support Services Market for Biopharmaceutical Processing and Consumables, by Country/Region, 2022–2031 (USD Million)
Table 40 Global Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 41 Global Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 42 Global Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, Country/Region, 2022–2031 (USD Million)
Table 43 List of Monoclonal Antibodies Under Review in the U.S. and Europe
Table 44 Global Biopharmaceutical Processing Equipment and Consumables Market for Monoclonal Antibody Production, Country/Region, 2022–2031 (USD Million)
Table 45 Global Biopharmaceutical Processing Equipment and Consumables Market for Therapeutic Protein Production, Country/Region, 2022–2031 (USD Million)
Table 46 Global Biopharmaceutical Processing Equipment and Consumables Market for Vaccine Production, Country/Region, 2022–2031 (USD Million)
Table 47 Global Biopharmaceutical Processing Equipment and Consumables Market for Cell and Gene Therapy, Country/Region, 2022–2031 (USD Million)
Table 48 Global Biopharmaceutical Processing Equipment and Consumables Market for Research Bioproduction, Country/Region, 2022–2031 (USD Million)
Table 49 Global Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022-2031 (USD Million)
Table 50 Global Biopharmaceutical Processing Equipment and Consumables Market for Pharmaceutical & Biopharmaceutical Companies, by Country/Region, 2022-2031 (USD Million)
Table 51 Global Biopharmaceutical Processing Equipment and Consumables Market for CDMO, by Country/Region, 2022–2031 (USD Million)
Table 52 Global Biopharmaceutical Processing Equipment and Consumables Market for Academic & Research Institutes, by Country/Region, 2022–2031 (USD Million)
Table 53 Global Biopharmaceutical Processing Equipment and Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 54 Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Country, 2022–2031 (USD Million)
Table 55 Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 56 Europe: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 57 Europe: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 58 Europe: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 59 Europe: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 60 Europe: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 61 Europe: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 62 Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 63 Europe: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 64 Europe: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 65 Germany: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 66 Germany: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 67 Germany: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 68 Germany: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 69 Germany: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 70 Germany: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 71 Germany: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 72 Germany: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 73 Germany: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 74 Germany: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 75 France: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 76 France: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 77 France: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 78 France: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 79 France: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 80 France: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 81 France: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 82 France: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 83 France: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 84 France: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 85 U.K.: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 86 U.K.: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 87 U.K.: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 88 U.K.: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 89 U.K.: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 90 U.K.: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 91 U.K.: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 92 U.K.: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 93 U.K.: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 94 U.K.: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 95 Italy: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 96 Italy: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 97 Italy: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 98 Italy: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 99 Italy: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 100 Italy: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 101 Italy: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 102 Italy: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 103 Italy: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 104 Italy: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 105 Spain: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 106 Spain: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 107 Spain: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 108 Spain: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 109 Spain: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 110 Spain: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 111 Spain: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 112 Spain: Biopharmaceutical Processing Equipment and Consumables Market, By Application, 2022–2031 (USD Million)
Table 113 Spain: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 114 Spain: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 115 Ireland: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 116 Ireland: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 117 Ireland: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 118 Ireland: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 119 Ireland: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 120 Ireland: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 121 Ireland: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 122 Ireland: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 123 Ireland: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 124 Ireland: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 125 Denmark: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 126 Denmark: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 127 Denmark: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 128 Denmark: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 129 Denmark: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 130 Denmark: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 131 Denmark: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 132 Denmark: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 133 Denmark: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 134 Denmark: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 135 Belgium: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 136 Belgium: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 137 Belgium: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 138 Belgium: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 139 Belgium: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 140 Belgium: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 141 Belgium: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 142 Belgium: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 143 Belgium: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 144 Belgium: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 145 Switzerland: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 146 Switzerland: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 147 Switzerland: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 148 Switzerland: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 149 Switzerland: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 150 Switzerland: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 151 Switzerland: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 152 Switzerland: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 153 Switzerland: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 154 Switzerland: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 155 Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 156 Rest of Europe: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 157 Rest of Europe: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 158 Rest of Europe: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 159 Rest of Europe: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 160 Rest of Europe: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 161 Rest of Europe: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 162 Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 163 Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 164 Rest of Europe: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 165 North America: Biopharmaceutical Processing Equipment and Consumables Market, by Country, 2022–2031 (USD Million)
Table 166 North America: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 167 North America: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 168 North America: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 169 North America: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 170 North America: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 171 North America: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 172 North America: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 173 North America: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 174 North America: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 175 North America: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 176 U.S.: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 177 U.S.: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 178 U.S.: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 179 U.S.: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 180 U.S.: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 181 U.S.: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 182 U.S.: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 183 U.S.: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 184 U.S.: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 185 U.S.: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 186 Canada: Biopharmaceutical Processing Equipment and Consumables Market by Product Type, 2022–2031 (USD Million)
Table 187 Canada: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 188 Canada: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 189 Canada: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 190 Canada: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 191 Canada: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 192 Canada: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 193 Canada: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 194 Canada: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 195 Canada: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 196 Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Country/Region, 2022–2031 (USD Million)
Table 197 Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 198 Asia-Pacific: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 199 Asia-Pacific: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 200 Asia-Pacific: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 201 Asia-Pacific: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 202 Asia-Pacific: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 203 Asia-Pacific: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 204 Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 205 Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 206 Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 207 China: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 208 China: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 209 China: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 210 China: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 211 China: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 212 China: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 213 China: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 214 China: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 215 China: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 216 China: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 217 India: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 218 India: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 219 India: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 220 India: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 221 India: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 222 India: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 223 India: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 224 India: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 225 India: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 226 India: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 227 Japan: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 228 Japan: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 229 Japan: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 230 Japan: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 231 Japan: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 232 Japan: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 233 Japan: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 234 Japan: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 235 Japan: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 236 Japan: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 237 South Korea: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 238 South Korea: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 239 South Korea: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 240 South Korea: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 241 South Korea: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 242 South Korea: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 243 South Korea: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 244 South Korea: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 245 South Korea: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 246 South Korea: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 247 Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2022–2031 (USD Million)
Table 248 Rest of Asia-Pacific: Chromatography Equipment and Consumables Market, by Type, 2022–2031 (USD Million)
Table 249 Rest of Asia-Pacific: Bioreactors Market, by Type, 2022–2031 (USD Million)
Table 250 Rest of Asia-Pacific: Cell Culture Products Market, by Type, 2022–2031 (USD Million)
Table 251 Rest of Asia-Pacific: Cell Culture Media Market, by Physical Form, 2022–2031 (USD Million)
Table 252 Rest of Asia-Pacific: Cell Culture Media Market, by Type, 2022–2031 (USD Million)
Table 253 Rest of Asia-Pacific: Cell Culture Media Market, by Source, 2022–2031 (USD Million)
Table 254 Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2022–2031 (USD Million)
Table 255 Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 256 Rest of Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 257 Latin America: Biopharmaceutical Processing Equipment and Consumables Market by Product Type, 2022–2031 (USD Million)
Table 258 Latin America: Chromatography Equipment and Consumables Market by Type, 2022–2031 (USD Million)
Table 259 Latin America: Bioreactors Market by Type, 2022–2031 (USD Million)
Table 260 Latin America: Cell Culture Products Market by Type, 2022–2031 (USD Million)
Table 261 Latin America: Cell Culture Media Market by Physical Form, 2022–2031 (USD Million)
Table 262 Latin America: Cell Culture Media Market by Type, 2022–2031 (USD Million)
Table 263 Latin America: Cell Culture Media Market by Source, 2022–2031 (USD Million)
Table 264 Latin America: Biopharmaceutical Processing Equipment and Consumables Market by Application, 2022–2031 (USD Million)
Table 265 Latin America: Biopharmaceutical Processing Equipment and Consumables Market Size for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 266 Latin America: Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2022–2031 (USD Million)
Table 267 Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market by Product Type, 2022–2031 (USD Million)
Table 268 Middle East & Africa: Chromatography Equipment and Consumables Market by Type, 2022–2031 (USD Million)
Table 269 Middle East & Africa: Bioreactors Market by Type, 2022–2031 (USD Million)
Table 270 Middle East & Africa: Cell Culture Products Market by Type, 2022–2031 (USD Million)
Table 271 Middle East & Africa: Cell Culture Media Market by Physical Form, 2022–2031 (USD Million)
Table 272 Middle East & Africa: Cell Culture Media Market by Type, 2022–2031 (USD Million)
Table 273 Middle East & Africa: Cell Culture Media Market by Source, 2022–2031 (USD Million)
Table 274 Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market by Application, 2022–2031 (USD Million)
Table 275 Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market Size for Commercial Bioproduction, by Type, 2022–2031 (USD Million)
Table 276 Middle East & Africa: Biopharmaceutical Processing Equipment and Consumables Market by End User, 2022–2031 (USD Million)
Table 277 Recent Developments, by Company, 2021-2024
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2024 Vs. 2031 (USD Million)
Figure 8 Global Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 9 Global Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 10 Biopharmaceutical Processing Equipment and Consumables Market, by Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 Biopharmaceutical R&D Expenditure, 2015-2025 (USD Billion)
Figure 13 Porter's Five Forces Analysis
Figure 14 Global Biopharmaceutical Processing Equipment and Consumables Market, by Product Type, 2024 Vs. 2031 (USD Million)
Figure 15 Number of Biologics Approved by the FDA Per Year (2018–2023)
Figure 16 Global Biopharmaceutical Processing Equipment and Consumables Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 17 Global COVID-19 Vaccine Production Capacity, 2021–2023 (Doses in Billion)
Figure 18 Global Biopharmaceutical Processing Equipment and Consumables Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 19 Global Biopharmaceutical Processing Equipment and Consumables Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 20 Europe: Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Figure 21 France: Health Expenditure (USD Per Capita) 2017 Vs. 2019 Vs. 2021
Figure 22 Number of Biotech Firms in Italy 2018–2022
Figure 23 Belgium Pharmaceutical Production, 2018-2021 (USD Million)
Figure 24 North America: Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Figure 25 Asia-Pacific: Biopharmaceutical Processing Equipment and Consumables Market Snapshot
Figure 26 Key Growth Strategies Adopted by Leading Players, 2021-2024
Figure 27 Biopharmaceutical Processing Equipment and Consumables Market: Competitive Benchmarking (Part 1)
Figure 28 Biopharmaceutical Processing Equipment and Consumables Market: Competitive Benchmarking (Part 2)
Figure 29 Biopharmaceutical Processing Equipment and Consumables Market: Competitive Benchmarking, by Region
Figure 30 Competitive Dashboard: Biopharmaceutical Processing Equipment and Consumables Market
Figure 31 Market Share Analysis: Biopharmaceutical Processing Equipment and Consumables Industry, 2023
Figure 32 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
Figure 33 Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 34 Sartorius AG: Financial Snapshot (2023)
Figure 35 Danaher Corporation: Financial Overview (2023)
Figure 36 Merck KGaA: Financial Overview (2023)
Figure 37 3M Company: Financial Snapshot (2023)
Figure 38 Bio-Rad Laboratories, Inc.: Financial Snapshot (2023)
Figure 39 Eppendorf SE: Financial Overview (2023)
Figure 40 Repligen Corporation: Financial Snapshot (2023)
Author Name:
Related Tag:
Biopharmaceutical Processing Equipment and Consumables Market
Biopharmaceuticals Manufacturing
Biopharmaceutical Processing
Biosimilars Processing
Commercial Bioproduction
Research Bioproduction
Processing Equipment and Consumables
Antibody Production
Biomanufacturing
Biologics Manufacturing
Proudly Partnering With Enterprises Around the Globe
Related Tag:
Biopharmaceutical Processing Equipment and Consumables Market
Biopharmaceuticals Manufacturing
Biopharmaceutical Processing
Biosimilars Processing
Commercial Bioproduction
Research Bioproduction
Processing Equipment and Consumables
Antibody Production
Biomanufacturing
Biologics Manufacturing
Quick Contact
